News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

APP Pharmaceuticals and Fresenius SE Announce Clearance of APP Acquisition by U.S. Federal Trade Commission


9/2/2008 9:37:59 AM

SCHAUMBURG, Ill. & BAD HOMBURG V.D.H., Germany--(BUSINESS WIRE)--APP Pharmaceuticals, Inc. (Nasdaq:APPX) and Fresenius SE (XETRA:FRE) have received confirmation that the U.S. Federal Trade Commission (FTC) has completed its review of the proposed acquisition of APP Pharmaceuticals by Fresenius Kabi, a business segment of Fresenius SE. The FTC granted early termination of the waiting period under the Hart-Scott-Rodino Act without conditions. The German antitrust authorities had already approved the acquisition.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES